✦ LIBER ✦

P-506 Gemcitabine combined to carboplatin in malignant pleural mesothelioma: a multicentric phase II study

✍ Scribed by Gino Favaretto, Adolfo; Aversa, Savina M.L.; Paccagnella, Adriano; De Pangher Manzini, Vincenzo; Oniga, Francesco; Stefani, Micaela; Rea, Federico; Bortolotti, Luigi; Loreggian, Lucio; Monfardini, Silvio

Book ID: 118572202
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 193 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92473-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.

Multicentre phase II study of gemcitabin

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

✍ van Haarst, J M W; Baas, P; Manegold, C h; Schouwink, J H; Burgers, J A; de Brui 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

Carboplatin and Gemcitabine Chemotherapy

Carboplatin and Gemcitabine Chemotherapy for Malignant Pleural Mesothelioma: A Phase II Study of the GSTPV

✍ Savina M.L. Aversa; Adolfo G. Favaretto 📂 Article 📅 1999 🏛 CIG Media Group, LP. 🌐 English ⚖ 84 KB

Carboplatin and gemcitabine chemotherapy

Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma (MPM): a phase II study of the GSTPV

✍ Aversa, SML; Arcuri, C; De Pangher, V; Favaretto, A; Endrizzi, L; Sartore, F; Gi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 131 KB

57 Gemcitabine (G) in malignant pleural

57 Gemcitabine (G) in malignant pleural mesothelioma (MPM): A phase II study

✍ Van Meerbeeck, J.P.; Baas, P.; Debruyne, C.; Groen, H.J.M.; Manegold, C.H.; Ardi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 307 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo